Literature DB >> 31342852

Virtual vs traditional care settings for low-acuity urgent conditions: An economic analysis of cost and utilization using claims data.

Tim Lovell1, Jordan Albritton1, Joe Dalto1, Cheryl Ledward1, William Daines2.   

Abstract

BACKGROUND: On-demand, direct-to-consumer video (or virtual) visits represent one of the fastest growing telemedicine services. Due to the absence of an in-person physical examination, some question the effectiveness, efficiency and value of virtual care visits. To address these questions, we conducted a retrospective, cross-sectional review of Intermountain Healthcare's virtual care programme.
METHOD: This study used SelectHealth claims for virtual, urgent, primary and emergency care delivered between 1 April 2016-31 March 2017. We included all claims with primary diagnosis from the nine most common categories for virtual care. A secondary data source included survey data indicating how virtual visits redirect care.
RESULTS: We matched 1531 virtual visit claims with claims from urgent (4377), primary (4388) and emergency care (2285). There were no differences in follow-up rates between virtual and urgent care and no differences in antibiotic use between virtual and urgent or primary care. Virtual care was significantly lower than all other care settings in utilization of laboratory and imaging services, index visit cost and total costs over 21 days.
CONCLUSIONS: This study affirmed lower cost for virtual care without an associated increase in overall follow-up rates or antibiotic use when compared with urgent or primary care. This suggests that virtual visits are can be used to lower the total cost of care for applicable conditions. The implications are that virtual visits help lower operational costs of providing care, particularly in integrated systems with capitated reimbursement. Under the right circumstances, the increased adoption of virtual care should lead to greater savings.

Keywords:  Cost-effectiveness; telecare; telehealth; virtual healthcare

Mesh:

Year:  2019        PMID: 31342852     DOI: 10.1177/1357633X19861232

Source DB:  PubMed          Journal:  J Telemed Telecare        ISSN: 1357-633X            Impact factor:   6.184


  6 in total

1.  Impact of rurality on melanoma diagnosis in Utah.

Authors:  Tawnya L Bowles; Carol Sweeney; John Snyder; Jesse Gygi; Brad Bott; Daniel Wray; Timothy J Yeatman; William T Sause
Journal:  Melanoma Manag       Date:  2021-03-04

Review 2.  The Use of Virtual Care in Patients with Hematologic Malignancies: A Scoping Review.

Authors:  Adam Suleman; Abi Vijenthira; Alejandro Berlin; Anca Prica; Danielle Rodin
Journal:  Curr Oncol       Date:  2022-02-07       Impact factor: 3.677

3.  Trends in Remote Health Care Consumption in Sweden: Comparison Before and During the First Wave of the COVID-19 Pandemic.

Authors:  Veronica Milos Nymberg; Lina Maria Ellegård; Gustav Kjellsson; Moa Wolff; Beata Borgström Bolmsjö; Thorne Wallman; Susanna Calling
Journal:  JMIR Hum Factors       Date:  2022-02-02

4.  Exploring agreement and feasibility between virtual home visits and in-person home visits for peritoneal dialysis patients-a paired study.

Authors:  Jin Chen; Bo Zheng; Lijuan Yin; Qin Zhou; Wenshu Liu; Pengli Li; Xiuxiu Zhao; Xiuling Chen; Yi Li; Hanlu Ding; Guisen Li
Journal:  Ren Fail       Date:  2022-12       Impact factor: 2.606

5.  Antimicrobial Prescribing in the Telehealth Setting: Framework for stewardship during a period of rapid acceleration within primary care.

Authors:  Kathryn Sine; Haley Appaneal; David Dosa; Kerry L LaPlante
Journal:  Clin Infect Dis       Date:  2022-07-30       Impact factor: 20.999

6.  Outpatient antibiotic prescribing for common infections via telemedicine versus face-to-face visits: Systematic literature review and meta-analysis.

Authors:  Hiroyuki Suzuki; Alexandre R Marra; Shinya Hasegawa; Daniel J Livorsi; Michihiko Goto; Eli N Perencevich; Michael E Ohl; Jennifer DeBerg; Marin L Schweizer
Journal:  Antimicrob Steward Healthc Epidemiol       Date:  2021-08-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.